-
respiratory Article
Dupilumab—A Potential New Biologic for Chronic Rhinosinusitis with Nasal Polyps
Kevin Hur, Robert C KernUS Respiratory & Pulmonary Diseases. 2020;5(1):Epub ahead of publication -
COVID-19
The Implications of COVID-19 for Patients with Pulmonary Disease
C Lee Cohen and Carolyn D’Ambrosio -
Interstitial Lung Disease
Nintedanib—A Potential New Therapy for Systemic Sclerosis-associated Interstitial Lung Disease
Tejaswini Kulkarni, Audrey Haywood, Anoop M NambiarUS Respiratory and Pulmonary Diseases. 2020;5(1):Epub ahead of print. -
COVID-19
COVID-19, Asthma and Allergies — What We Know So Far
Mário Morais-Almeida and Ignacio Ansotegui -
COVID-19
COVID-19 Era With or Without Lockdown – Tuberculosis Control Measures Through Tuberculosis Program Clinics Must Go On
Juzar Ali MD Louisiana State University (LSU) Alumni Klein Professor of Medicine, Section of Pulmonary/Critical Care at LSU Health Sciences Center (LSUHSC) and Medical Director, LSU- Wetmore –Office of Public Health, TB Program, New Orleans, LA, USA -
COVID-19
Expert interview with Dr Marina Garassino: COVID-19 and lung cancer – current advice and self-care
Marina Chiara Garassino, Head of the thoracic oncology unit, National Cancer Institute of Milan, Italy -
Airway and Lung Infection
Respiratory Syncytial Virus – the Quest for Effective Prevention
Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK -
COVID-19
COVID-19 – What Have We Learned So Far?
Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK -
Thoracic Oncology
Evidence and E-cigarettes – The English Perspective
Martin McKeeEuropean Respiratory & Pulmonary Diseases. 2019;5(1):10–11 -
respiratory Article
Foreword–US Respiratory & Pulmonary Diseases. 2019;4(1):6
Carolyn M D’AmbrosioUS Respiratory & Pulmonary Diseases. 2019;4(1):6 -
Cystic Fibrosis
Elexacaftor-tezacaftor-ivacaftor—A Combination Therapy for Phe508del Cystic Fibrosis
Shijing Jia, Jennifer L Taylor-CousarUS Respiratory & Pulmonary Diseases. 2019;4(1):15–9 -
Asthma
Inhaled Corticosteroid Therapy—The Impact of Formulary Changes on Asthma Control
Scott BickelUS Respiratory & Pulmonary Diseases. 2019;4(1):10–11
